AQR Capital Management
MGNX icon

AQR Capital Management’s MacroGenics MGNX Stock Holding History

AQR Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-75,529
Closed -$91.4K – 3540
2025
Q2 		$91.4K Sell
75,529
-156,870
-68% -$228K ﹤0.01% 3195
2025
Q1 		$295K Sell
232,399
-86,671
-27% -$226K ﹤0.01% 2700
2024
Q4 		$1.04M Sell
319,070
-104,546
-25% -$377K ﹤0.01% 1872
2024
Q3 		$1.39M Buy
423,616
+280,455
+196% +$1.09M ﹤0.01% 1680
2024
Q2 		$608K Buy
143,161
+61,131
+75% +$595K ﹤0.01% 1970
2024
Q1 		$1.21M Sell
82,030
-50,344
-38% -$761K ﹤0.01% 1612
2023
Q4 		$1.27M Sell
132,374
-208,236
-61% -$1.44M ﹤0.01% 1519
2023
Q3 		$1.59M Buy
340,610
+120,263
+55% +$599K ﹤0.01% 1427
2023
Q2 		$1.18M Buy
220,347
+172,078
+356% +$1.06M ﹤0.01% 1484
2023
Q1 		$346K Sell
48,269
-57,279
-54% -$345K ﹤0.01% 1900
2022
Q4 		$708K Sell
105,548
-430,783
-80% -$2.36M ﹤0.01% 1686
2022
Q3 		$1.86M Buy
536,331
+395,809
+282% +$1.51M ﹤0.01% 1237
2022
Q2 		$415K Buy
+140,522
New +$739K ﹤0.01% 1748
2022
Q1 		– Sell
-20,733
Closed -$333K – 2257
2021
Q4 		$333K Sell
20,733
-14,061
-40% -$265K ﹤0.01% 1952
2021
Q3 		$729K Sell
34,794
-7,600
-18% -$183K ﹤0.01% 1712
2021
Q2 		$1.14M Sell
42,394
-12,972
-23% -$380K ﹤0.01% 1527
2021
Q1 		$1.76M Buy
55,366
+591
+1% +$14.4K ﹤0.01% 1270
2020
Q4 		$1.25M Buy
54,775
+5,463
+11% +$126K ﹤0.01% 1398
2020
Q3 		$1.24M Buy
+49,312
New +$1.35M ﹤0.01% 1315
2019
Q3 		– Sell
-15,870
Closed -$269K – 2140
2019
Q2 		$269K Buy
15,870
+3,751
+31% +$64.4K ﹤0.01% 1906
2019
Q1 		$218K Sell
12,119
-14,819
-55% -$256K ﹤0.01% 2052
2018
Q4 		$342K Buy
+26,938
New +$452K ﹤0.01% 1921
2017
Q4 		– Sell
-54,742
Closed -$1.01M – 2255
2017
Q3 		$1.01M Buy
54,742
+35,920
+191% +$622K ﹤0.01% 1670
2017
Q2 		$330K Buy
+18,822
New +$359K ﹤0.01% 2012
2016
Q2 		– Sell
-24,009
Closed -$450K – 2238
2016
Q1 		$450K Sell
24,009
-28,163
-54% -$536K ﹤0.01% 1874
2015
Q4 		$1.62M Buy
52,172
+3,803
+8% +$116K ﹤0.01% 1346
2015
Q3 		$1.04M Sell
48,369
-24,895
-34% -$781K ﹤0.01% 1408
2015
Q2 		$2.78M Buy
73,264
+47,064
+180% +$1.55M 0.01% 1039
2015
Q1 		$822K Buy
+26,200
New +$888K ﹤0.01% 1503

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management's MGNX Position: Q3 2025 in Review

AQR Capital Management sold out of MacroGenics (MGNX) in Q3 2025, closing a stake of 75,529 shares — an estimated $91.4K sold.

AQR Capital Management first reported a position in MGNX in Q1 2015 and held it in 29 quarters. The position peaked at $2.78M in Q2 2015. 104 funds tracked by Wall St. Rank hold MGNX as of Q3 2025.

  • AQR Capital Management reported no remaining MacroGenics position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 75,529 MacroGenics shares in Q3 2025, an estimated $91.4K.
  • AQR Capital Management first reported a position in MacroGenics in Q1 2015 and held it in 29 quarters.
  • AQR Capital Management's MacroGenics position peaked at $2.78M in Q2 2015.
  • 104 funds tracked by Wall St. Rank held MacroGenics as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.